Oncogenic receptor tyrosine kinase (RTK) translocations in a subset of quadruple wild-type gastrointestinal stromal tumors (GIST).

被引：0
|
作者：
Heinrich, Michael C.
Kang, Guhyun
Warrick, Andrea
Corless, Christopher L.
Beadling, Carol
机构：
[1] OHSU, Knight Canc Inst, Portland, OR USA
[2] Inje Univ Paik Hosp, Dept Pathol, Seoul, South Korea
[3] OHSU, Knight Diagnost Lab, Portland, OR USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.11012
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11012
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Oncogenic signaling by Kit tyrosine kinase occurs selectively on the Golgi apparatus in gastrointestinal stromal tumors
    Obata, Y.
    Horikawa, K.
    Takahashi, T.
    Akieda, Y.
    Tsujimoto, M.
    Fletcher, J. A.
    Esumi, H.
    Nishida, T.
    Abe, R.
    ONCOGENE, 2017, 36 (26) : 3661 - 3672
  • [22] Oncogenic signaling by Kit tyrosine kinase occurs selectively on the Golgi apparatus in gastrointestinal stromal tumors
    Y Obata
    K Horikawa
    T Takahashi
    Y Akieda
    M Tsujimoto
    J A Fletcher
    H Esumi
    T Nishida
    R Abe
    Oncogene, 2017, 36 : 3661 - 3672
  • [23] Molecular and clinicopathological features of KIT/PDGFRA wild-type gastrointestinal stromal tumors
    Nishida, Toshirou
    Naito, Yoichi
    Takahashi, Tsuyoshi
    Saito, Takuro
    Hisamori, Shigeo
    Manaka, Dai
    Ogawa, Katsuhiro
    Hirota, Seiichi
    Ichikawa, Hitoshi
    CANCER SCIENCE, 2024, 115 (03) : 894 - 904
  • [24] Classification of KIT/PDGFRA wild-type gastrointestinal stromal tumors: implications for therapy
    Huss, Sebastian
    Elges, Sandra
    Trautmann, Marcel
    Sperveslage, Jan
    Hartmann, Wolfgang
    Wardelmann, Eva
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (06) : 623 - 628
  • [25] Wild-type gastrointestinal stromal tumors with NTRK gene fusions: A clinicopathological study
    Zhang, Haidong
    Yin, Xiaonan
    Zhang, Bo
    Chen, Zhixin
    ASIAN JOURNAL OF SURGERY, 2023, 46 (10) : 4435 - 4436
  • [26] Whole genome sequencing of KIT/PDGFRA wild-type gastrointestinal stromal tumors
    Ohshima, Keiichi
    Fujiya, Keiichi
    Nagashima, Takeshi
    Ohnami, Sumiko
    Kamada, Fukumi
    Naruoka, Akane
    Shimoda, Yuji
    Hatakeyama, Keiichi
    Serizawa, Masakuni
    Ohnami, Shumpei
    Bando, Etsuro
    Sugino, Takashi
    Urakami, Kenichi
    Akiyama, Yasuto
    Terashima, Masanori
    Yamaguchi, Ken
    CANCER SCIENCE, 2021, 112 : 269 - 269
  • [27] Genetic and epigenetic profiling of KIT/PDGFRA wild-type gastrointestinal stromal tumors
    Ohshima, Keiichi
    Fujiya, Keiichi
    Nagashima, Takeshi
    Ohnami, Sumiko
    Kamada, Fukumi
    Naruoka, Akane
    Hatakeyama, Keiichi
    Serizawa, Masakuni
    Ohnami, Shumpei
    Bando, Etsuro
    Sugino, Takashi
    Urakami, Kenichi
    Akiyama, Yasuto
    Mochizuki, Tohru
    Terashima, Masanori
    Yamaguchi, Ken
    CANCER SCIENCE, 2022, 113 : 738 - 738
  • [28] Results of SARC 022, a phase II multicenter study of linsitinib in pediatric and adult wild-type (WT) gastrointestinal stromal tumors (GIST).
    von Mehren, Margaret
    George, Suzanne
    Heinrich, Michael C.
    Schuetze, Scott
    Belinsky, Martin G.
    Janeway, Katherine A.
    Rink, Lori
    Ganjoo, Kristen N.
    Yu, Jian Qin
    Yap, Jeffrey T.
    Wright, John Joseph
    Van den Abbeele, Annick D.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [29] Pediatric KIT-wild-type and platelet-derived growth factor receptor α-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors
    Janeway, Katherine A.
    Liegl, Bernadette
    Harlow, Amy
    Le, Claudia
    Perez-Atayde, Antonio
    Kozakewich, Harry
    Corless, Christopher L.
    Heinrich, Nflchael C.
    Fletcher, Jonathan A.
    CANCER RESEARCH, 2007, 67 (19) : 9084 - 9088
  • [30] Molecularly-guided therapeutic options beyond tyrosine kinase inhibitors (TKIs) for gastrointestinal stromal tumors (GIST)
    Feldman, Rebecca
    Gatalica, Zoran
    Reddy, Sandeep K.
    Chawla, Sant P.
    Sankhala, Kamalesh Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
12345